Literature DB >> 6199436

The importance of the K1 capsule in invasive infections caused by Escherichia coli.

A S Cross, P Gemski, J C Sadoff, F Orskov, I Orskov.   

Abstract

We examined 534 clinical isolates of Escherichia coli for sensitivity to rough lipopolysaccharide-specific and K1-specific phages. Twenty-eight percent of bacteremic isolates were sensitive to rough-specific phages. Forty-two percent of these strains, against only 20% of bacteremic isolates insensitive to rough-specific phages, had K1 capsule (P less than 0.001). K1-positive strains were usually resistant to phagocytic killing, whereas strains lacking the K1 capsule were more likely to be killed regardless of capsular type. Eighty-two percent of strains were typable with O-specific, 57% with K-specific, and 74% with H-specific antisera. Sixty percent of E coli were agglutinated by only 10 O-specific antisera. K1 was the most common capsular type, followed by K5, K2, and K12, whereas four H antigens accounted for nearly half of the H-typable strains. We conclude that (1) the combination of rough-specific and K1-specific phage sensitivity defines functionally similar groups of bacteria and (2) a polyvalent vaccine against invasive E coli is possible given the relatively limited number of invasive O:K:H serotypes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199436     DOI: 10.1093/infdis/149.2.184

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

1.  Loss of resistance to ingestion and phagocytic killing by O(-) and K(-) mutants of a uropathogenic Escherichia coli O75:K5 strain.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2).

Authors:  Y Arakawa; M Ohta; R Wacharotayankun; M Mori; N Kido; H Ito; T Komatsu; T Sugiyama; N Kato
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  HbiF regulates type 1 fimbriation independently of FimB and FimE.

Authors:  Yi Xie; Yufeng Yao; Vitaliy Kolisnychenko; Ching-Hao Teng; Kwang Sik Kim
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

5.  Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.

Authors:  G Raponi; N Keller; B P Overbeek; M Rozenberg-Arska; K P van Kessel; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.

Authors:  M Trautmann; M Ruhnke; T Rukavina; T K Held; A S Cross; R Marre; C Whitfield
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

7.  Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Identification of Escherichia coli K1 antigen.

Authors:  A Cross; I Orskov; F Orskov; J Sadoff; P Gemski
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

9.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains.

Authors:  H Frasa; J Procee; R Torensma; A Verbruggen; A Algra; M Rozenberg-Arska; K Kraaijeveld; J Verhoef
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.